Global IVD Quality Control Market Size, Share, Growth Analysis, By Product and Service, By Application, By Manufacturer type - Industry Forecast 2024-2031

Global IVD Quality Control Market size was valued at USD 1.10 billion in 2022 and is poised to grow from USD 1.11 billion in 2023 to USD 1.5 billion by 2031, growing at a CAGR of 4.10% during the forecast period (2024-2031).

The global IVD quality control market is experiencing substantial growth, driven by factors such as the pivotal role played by clinical laboratories, the expanding geriatric demographic, heightened demand for external quality assessment initiatives, increased uptake of point-of-care instruments in developed regions, and the surge in third-party quality control measures. Furthermore, the escalating incidence of infectious diseases, HIV, and cancers necessitating advanced diagnostics and rigorous quality monitoring further bolster market expansion. For instance, data from the Joint United Nations Program on HIV and AIDS reveal that in 2019, approximately 24.5 million HIV patients received antiretroviral therapy, emphasizing the need for swift diagnostic solutions and robust quality assurance mechanisms. However, challenges persist, including the added burdens placed on laboratories for quality control, unfavorable reimbursement conditions for IVD tests, and the absence of mandatory regulatory frameworks for clinical laboratory accreditation in numerous emerging economies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global IVD Quality Control Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global IVD Quality Control Market Segmental Analysis

Global In Vitro Diagnostics (IVD) Quality Control market is segmented into product and service, application, manufacturer type, end user, and region. Based on product and service, the IVD Quality Control Market is segmented into quality control products, data management solutions, and quality assurance services. In terms of application, the global market is classified into clinical chemistry, immunochemistry/immunoassay, hematology, molecular diagnostics, coagulation and hemostasis, microbiology, and others. With respect to categorization by manufacturer type, the global IVD Quality Control Market is divided into third-party control manufacturers, and original equipment manufacturers. Based on end users, the global IVD Quality Control Market is segmented into hospitals, home care settings, clinical laboratories, and academic and research institutes.

Drivers of the Global IVD Quality Control Market

The surge in the prevalence of diverse diseases has led to a rise in the demand for laboratory tests, prompting an expansion in both public and commercial laboratory facilities. The swift spread of COVID-19 since December 2019 further intensified the need for diagnostic testing, prompting governmental bodies to establish supplementary laboratories to bolster testing capacity, consequently fueling market growth.

Restraints in the Global IVD Quality Control Market

Establishing quality control (QC) procedures in hospital settings requires both financial investment and specialized knowledge. Clinical laboratories dealing with low volume QC procedures often find the adoption of such protocols financially burdensome. This challenge is compounded by budgetary limitations in many healthcare facilities and labs, leading to a reduced uptake of QC procedures.

Market Trends of the Global IVD Quality Control Market

As diseases become more widespread, medical device companies are increasingly prioritizing the advancement of technologically sophisticated diagnostic tools. Hospitals and laboratories are increasingly favoring point-of-care testing devices to obtain precise real-time data, leading to a surge in demand for such devices and driving market growth.